The measurement of caffeine concentration in scalp hair as an indicator of liver function

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 6, 1996, Pages 660-664

  Mizuno, Atsuhiro ^a   Uematsu, Toshihiko ^a   Gotoh, Seiichi ^a   Katoh, Eiichi ^a   Nakashima, Mitsuyoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CHLOROFORM; PROTEINASE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HEPATITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; LIVER METABOLISM; MALE; MASS SPECTROMETRY; METABOLIC CAPACITY; QUESTIONNAIRE; SCALP HAIR; TISSUE LEVEL;

EID: 0030057375     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05992.x     Document Type: Article

References (29)

1. Andreasen, P. B., Ranek, L., Statland, B. E., Tygstrup, N. (1974) Clearance of antipyrine - dependence of quantitative liver function. Eur. J. Clin. Invest. 4: 129-134
2. Arnaud, M. J. (1989) The pharmacology of caffeine. Prog. Drug Res. 31: 273-313
3. Benowitz, N. L. (1990) Clinical pharmacology of caffeine. Annu. Rev. Med. 41:277-88
4. Bircher, J., Kupfer, A., Gikalow, J., Preisig, R. (1976) Aminopyrine demethylation measured by breath analysis in cirrhosis. Clin. Pharmacol. Ther. 20: 484-492
5. Bunker, M. L., Williams, M. (1979) Caffeine content of common beverages. J. Am. Diet Assoc. 74: 28-33
6. Haecki, W., Bircher, J., Preisig, R. (1976) A new look at the plasma disappearance of sulfobromophthalein (BPS): correlation with BPS transport maximum and the hepatic plasma flow in man. J. Lab. Clin. Med. 88: 1019-1031
7. Kalow, W., Tang, B. K. (1993) The use of caffeine for enzyme assay: a critical appraisal. Clin. Pharmacol. Ther. 53: 503-514
8. Kato, I., Tominaga, S. (1990) Kohi inyousya to koutya inyousya no tokutyou to hikaku (in Japanese). Jpn. J. Clin. Nutr. 76: 277-284
9. Lelo, A., Miners, J. O., Robson, R., Birken, D. J. (1986) Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines. Clin. Pharmacol. Ther. 39: 54-59
10. Lewis, F. W., Rector, W. G. (1992) Caffeine clearance in cirrhosis. The value of simplified determinations of liver metabolic capacity. J. Hepatol. 14: 157-162
11. Matsuno, H., Uematsu, T., Nakashima, M. (1990) The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history. Br. J. Clin. Pharmacol. 29: 187-194
12. Miescher, G., Paumgartner, G., Preisig, R. (1983) Portal-systemic spillover of bile acids: a study of mechanisms using ursodeoxycholic acid. Eur. J. Clin. Invest. 13: 439-445
13. Miyazawa, N., Uematsu, T., Nakashima, M. (1991) Ofloxacin in human hair determined by high performance liquid chromatography. Forensic Sci. Int. 51: 65-77
14. Mizuno, A., Uematsu, T., Oshiam, A., Nakamura, M., Nakashima, M. (1993) Analysis of nicotine content of hair for assessing individual cigarette-smoking behavior, Ther, Drug Monit. 15: 99-104
15. Paumgartner, G. ( 1975) The handling of indocyanine green by the liver. Schweiz. Med. Wochenschr. 105: 5-30
16. Renner, E., Weitholtz, H., Huguenin, P., Arnaud, M. J., Preisig, R. (1984) Caffeine: a model compound for measuring liver function. Hepatology 4: 38-46
17. Sato, R., Uematsu, T., Sato, R., Yamaguchi, S., Nakashima, M. (1989) Human scalp hair as evidence of individual dosage history of haloperidol: prospective study. Ther. Drug Monit. 11: 686-691
18. Suzuki, Y., Uematsu, T., Mizuno, A., Fujii, K., Nakashima, M. (1989) Determination of caffeine in saliva by high-performance liquid chromatography: new sampling method for saliva using filter paper. Ther. Drug Monit. 11: 88-91
19. Tserng, K. Y. (1983) Gas chromatographic-mass spectrometric quantitation of theophylline and its metabolites in biological fluids. J. Pharm. Sci. 72: 526-529
20. Tygstrup, N. (1966) Determination of the hepatic elimination capacity of galactose by single injection. Scand. J. Clin. Invest. 18 (Suppl. 92): 118-125
21. Uematsu, T. (1993) Therapeutic drug monitoring in hair samples: principles and practice. Clin. Pharmacokinet. 25: 83-87
22. Uematsu, T., Sato, R. (1990) Human scalp hair as evidence of individual dosage history of haloperidol: longer term follow-up study. Ther. Drug Monit. 12: 582-583
23. Uematsu, T., Sato, R., Suzuki, K., Yamaguchi, S., Nakashima, M. (1989) Human scalp hair as evidence of individual dosage history of haloperidol: method and retrospective study. Eur. J. Clin. Pharmacol. 37: 239-244
24. Uematsu, T., Sato, R., Fujimori, O., Nakashima, M. (1990) Human scalp hair as evidence of individual dosage history of haloperidol: possible linkage of haloperidol excretion into hair with hair pigment. Arch. Dermatol. Res. 282: 120-125
25. Uematsu, T., Miyazawa, N., Nakashima, M. (1991a) The measurement of ofloxacin in hair as an index of exposure. Eur. J. Clin. Pharmacol. 40: 581-584
26. Uematsu, T., Yamada, K., Matsuno, H., Nakashima, N. (1991b) The measurement of haloperidol and reduced haloperidol in neonatal hair as an index of placental transfer of maternal haloperidol. Ther. Drug Monit. 13: 183-187
27. Uematsu, T., Miyazawa, N., Okazaki, O., Nakashima, N. (1992a) Possible effect of pigment on the pharmacokinetics of ofloxacin and its excretion in hair. J. Pharm. Sci. 81: 45-48
28. Uematsu, T., Matsuno, H., Sato, H., Hirayma, H., Matsumoto, K., Nakashima, M. (1992b) Steady-state pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patient and analysis of factors determining their concentrations in hair. J. Pharm. Sci. 81: 1008-1011
29. Weidner, G. (1985) Dietary sources of caffeine. N. Engl. J. Med. 313: 1421